


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31199091</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2146-3131</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Balkan medical journal</Title>
                <ISOAbbreviation>Balkan Med J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>MGMT Promoter Methylation in Patients with Rectal Adenocarcinoma After Chemoradiotherapy Treatment: Clinical Implications</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.4274/balkanmedj.galenos.2019.2018.12.93</ELocationID>
            <Abstract>
                <AbstractText Label="Aims">Resistance to preoperative chemoradiotherapy (CRT) in rectal adenocarcinoma has been correlated with the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT). We analyse the clinical relevance of MGMT in rectal adenocarcinoma treated with CRT followed by surgery.</AbstractText>
                <AbstractText Label="Methods">Tissue samples from 29 rectal adenocarcinoma patients were obtained after CRT. MGMT promoter methylation status was established by methylation-specific PCR. MGMT protein levels were determined by immunohistochemistry. Clinopathological variables including treatment regression grade, recurrence, lymph node invasion and stage and differentiation grade of the tumor were determined.</AbstractText>
                <AbstractText Label="Results">Our results showed that MGMT gene promoter was methylated in 81.5% of the samples. Most of the patients (88.9%) showed a low MGMT protein expression. MGMT methylation status no correlated to any of the clinicopathological variables determined in rectal adenocarcinomas selected to CRT.</AbstractText>
                <AbstractText Label="Conclusion">MGMT methylation status no correlated to clinicopathologic variables examined in rectal adenocarcinoma selected to CRT although its role as biomarker needs further investigation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Oliver</LastName>
                    <ForeName>Jaime A.</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>G칩mez-Mill치n</LastName>
                    <ForeName>Jaime</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiation Oncology, Universitary Hospital Virgen de la Victoria, M치laga, Spain</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Medina</LastName>
                    <ForeName>Jose A.</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiation Oncology, Universitary Hospital Virgen de la Victoria, M치laga, Spain</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cabeza</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy and Embryology, University of Granada, Granada, Spain</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biosanitary Institute of Granada (ibs. GRANADA), SAS-Universidad de Granada, Granada, Spain</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perazzoli</LastName>
                    <ForeName>Gloria</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biosanitary Institute of Granada (ibs. GRANADA), SAS-Universidad de Granada, Granada, Spain</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jimenez- Luna</LastName>
                    <ForeName>Cristina</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Doello</LastName>
                    <ForeName>Kevin</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Oncology Service, Universitary Hospital Virgen de las Nieves, Granada, Spain</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ortiz</LastName>
                    <ForeName>Raul</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy and Embryology, University of Granada, Granada, Spain</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biosanitary Institute of Granada (ibs. GRANADA), SAS-Universidad de Granada, Granada, Spain</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Turkey</Country>
            <MedlineTA>Balkan Med J</MedlineTA>
            <NlmUniqueID>101571817</NlmUniqueID>
            <ISSNLinking>2146-3123</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Rectal adenocarcinoma</Keyword>
            <Keyword MajorTopicYN="Y">chemoradiotherapy</Keyword>
            <Keyword MajorTopicYN="Y">MGMT</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31199091</ArticleId>
            <ArticleId IdType="doi">10.4274/balkanmedj.galenos.2019.2018.12.93</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

